Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Interest Coverage Ratio: 2009-2024

Historic Interest Coverage Ratio for Gyre Therapeutics (GYRE) over the last 6 years, with Mar 2024 value amounting to 25.62.

  • Gyre Therapeutics' Interest Coverage Ratio rose 147.23% to 25.62 in Q1 2024 from the same period last year, while for Mar 2024 it was -63.54, marking a year-over-year decrease of 254.43%. This contributed to the annual value of -25.92 for FY2023, which is 486.95% down from last year.
  • Per Gyre Therapeutics' latest filing, its Interest Coverage Ratio stood at 25.62 for Q1 2024, which was up 147.23% from 10.36 recorded in Q1 2023.
  • Over the past 5 years, Gyre Therapeutics' Interest Coverage Ratio peaked at 25.62 during Q1 2024, and registered a low of -2,300.00 during Q3 2020.
  • In the last 2 years, Gyre Therapeutics' Interest Coverage Ratio had a median value of 17.99 in 2024 and averaged 17.99.
  • Data for Gyre Therapeutics' Interest Coverage Ratio shows a peak YoY spiked of 147.23% (in 2024) over the last 5 years.
  • Over the past 3 years, Gyre Therapeutics' Interest Coverage Ratio (Quarterly) stood at -265.37 in 2020, then reached 10.36 in 2023, then spiked by 147.23% to 25.62 in 2024.
  • Its Interest Coverage Ratio stands at 25.62 for Q1 2024, versus 10.36 for Q1 2023 and -265.37 for Q4 2020.